Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Hillary Samples

Biographic Data

ID5545177
NAMEHillary Samples
GIVEN NAMESHillary
FAMILY NAMESamples
SIGNATURESAMPLES H
AFFILIATIONSRutgers, the State University of New Jersey
ORCID0000-0001-5773-3705
VERIFIEDYes
TOTAL WORKS9
TOTAL CITATIONS0
AUTHOR COUNT9
EDITOR COUNT0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2025
H-INDEX0
  • The T-MSIS Analytic Files (TAF) Analysis Reporting Checklist

    Open Access•William L Schpero, K John McConnell et al.•ARTICLE•JAMA Health Forum•2025

    The TAF Analysis Reporting Checklist represents a consensus effort to identify items researchers should report to promote transparency and reproducibility in TAF-based studies. This reporting is a key step in safeguarding the quality of research used to inform Medicaid policy

  • Trends in Access to Medications for Opioid Use Disorder

    Open Access•Sumedha Gupta, A R James et al.•ARTICLE•JAMA Health Forum•2025

    This cross-sectional study of Medicaid unwinding and filled buprenorphine prescriptions found that although shifts to commercial and self-pay sources mitigated some losses, rising self-pay reliance poses affordability barriers that threaten treatment continuity. Addressing access disparities is critical amid persistently high US overdose rates

  • How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013–2020? An application of a new state opioid poli…

    Open Access•Samantha M Doonan, Katherine Wheeler-Martin et al.•ARTICLE•International Journal of Drug…•2025

  • The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA

    Open Access•Sílvia S Martins, Emilie Bruzelius et al.•ARTICLE•International Journal of Drug…•2025

    Comparing individuals in MCL alone states to those in states without such laws, we found an inconsistent pattern of decreased odds of opioid outcomes, which were more pronounced among people reporting cannabis use. The pattern did not hold for individuals in RCL states. In line with a substitution-oriented perspective, findings suggests that MCLs may be associated with reductions in opioid use among people using cannabis but additional work to re…

  • Cannabis legalization and increasing cannabis use in the United States

    Open Access•David S Fink, Hillary Samples et al.•ARTICLE•International Journal of Drug…•2025

  • Association Between Legal Access to Medical Cannabis and Frequency of Non-Medical Prescription Opioid Use Among U.S. Adults

    Open Access•Hillary Samples, Natalie S Levy et al.•ARTICLE•International Journal of Mental…•2023

  • Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use

    Open Access•Emilie Bruzelius, Magdalena Cerdá et al.•ARTICLE•International Journal of Drug…•2023

  • A modified Delphi process to identify experts’ perceptions of the most beneficial and harmful laws to reduce opioid-related harm

    Open Access•Leah K Hamilton, Leah Hamilton et al.•ARTICLE•International Journal of Drug…•2022

  • Discussing Drug Use With Health Care Providers Is Associated With Perceived Need and Receipt of Drug Treatment Among Adults in the United States

    Pia M Mauro, Hillary Samples et al.•ARTICLE•Medical Care•2020•References: 28

    BACKGROUND: Drug treatment utilization is low despite a high public health burden of drug use disorders (DUDs). Engaging people at risk for DUDs across a broader range of health care settings may improve uptake of drug treatment. OBJECTIVES: To estimate the prevalence of drug use screening/discussions between health care providers and individuals with past-year drug use, and to assess the associations between drug use screening/discussions and pe…

No prominent works on this page.

  • Discussing Drug Use With Health Care Providers Is Associated With Perceived Need and Receipt of Drug Treatment Among Adults in the United States

    Pia M Mauro, Hillary Samples et al.•ARTICLE•Medical Care•2020•References: 28

    BACKGROUND: Drug treatment utilization is low despite a high public health burden of drug use disorders (DUDs). Engaging people at risk for DUDs across a broader range of health care settings may improve uptake of drug treatment. OBJECTIVES: To estimate the prevalence of drug use screening/discussions between health care providers and individuals with past-year drug use, and to assess the associations between drug use screening/discussions and pe…

  • A modified Delphi process to identify experts’ perceptions of the most beneficial and harmful laws to reduce opioid-related harm

    Open Access•Leah K Hamilton, Leah Hamilton et al.•ARTICLE•International Journal of Drug…•2022

  • Association Between Legal Access to Medical Cannabis and Frequency of Non-Medical Prescription Opioid Use Among U.S. Adults

    Open Access•Hillary Samples, Natalie S Levy et al.•ARTICLE•International Journal of Mental…•2023

  • Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use

    Open Access•Emilie Bruzelius, Magdalena Cerdá et al.•ARTICLE•International Journal of Drug…•2023

  • The T-MSIS Analytic Files (TAF) Analysis Reporting Checklist

    Open Access•William L Schpero, K John McConnell et al.•ARTICLE•JAMA Health Forum•2025

    The TAF Analysis Reporting Checklist represents a consensus effort to identify items researchers should report to promote transparency and reproducibility in TAF-based studies. This reporting is a key step in safeguarding the quality of research used to inform Medicaid policy

  • Trends in Access to Medications for Opioid Use Disorder

    Open Access•Sumedha Gupta, A R James et al.•ARTICLE•JAMA Health Forum•2025

    This cross-sectional study of Medicaid unwinding and filled buprenorphine prescriptions found that although shifts to commercial and self-pay sources mitigated some losses, rising self-pay reliance poses affordability barriers that threaten treatment continuity. Addressing access disparities is critical amid persistently high US overdose rates

  • How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013–2020? An application of a new state opioid poli…

    Open Access•Samantha M Doonan, Katherine Wheeler-Martin et al.•ARTICLE•International Journal of Drug…•2025

  • The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA

    Open Access•Sílvia S Martins, Emilie Bruzelius et al.•ARTICLE•International Journal of Drug…•2025

    Comparing individuals in MCL alone states to those in states without such laws, we found an inconsistent pattern of decreased odds of opioid outcomes, which were more pronounced among people reporting cannabis use. The pattern did not hold for individuals in RCL states. In line with a substitution-oriented perspective, findings suggests that MCLs may be associated with reductions in opioid use among people using cannabis but additional work to re…

  • Cannabis legalization and increasing cannabis use in the United States

    Open Access•David S Fink, Hillary Samples et al.•ARTICLE•International Journal of Drug…•2025

Medicine (8 works) · Opioid Use Disorder Treatment (7 works) · Internal Medicine (6 works) · Opioid (6 works) · Psychiatry (6 works) · Prenatal Substance Exposure Effects (5 works) · Substance Abuse Treatment and Outcomes (4 works) · Cannabis (3 works) · Cannabis and Cannabinoid Research (3 works) · Family medicine (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae